241 – 250 of 335
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
- Contribution to journal › Article
-
Mark
Risk factors for venous thrombosis in Swedish children and adolescents.
- Contribution to journal › Article
-
Mark
The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A.
- Contribution to journal › Article
-
Mark
Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis
- Contribution to journal › Article
-
Mark
Cost effectiveness of haemophilia treatment: a cross-national assessment.
- Contribution to journal › Article
-
Mark
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
- Contribution to journal › Letter
-
Mark
Long-term prophylaxis in von Willebrand disease
- Contribution to journal › Article
-
Mark
Protein C levels can be forecasted by global haemostatic tests in critically ill patients and predict long-term survival.
- Contribution to journal › Article
- 2004
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
- Contribution to journal › Article
-
Mark
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A
- Contribution to journal › Article
